Morin and Esculetin supplementation modulates c-myc induced energy metabolism and attenuates neoplastic changes in rats challenged with the procarcinogen 1,2 - dimethylhydrazine
- 1 February 2017
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 796, 20-31
- https://doi.org/10.1016/j.ejphar.2016.12.019
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology, New Delhi, India (BT/Bio-CARe/07/10037/2013-14)
This publication has 47 references indexed in Scilit:
- Targeting cellular metabolism to improve cancer therapeuticsCell Death & Disease, 2013
- Natural Compounds as Regulators of the Cancer Cell MetabolismInternational Journal of Cell Biology, 2013
- Human pyruvate kinase M2: A multifunctional proteinProtein Science, 2010
- Rethinking the Warburg Effect with Myc Micromanaging Glutamine MetabolismCancer Research, 2010
- Cancer as a metabolic diseaseNutrition & Metabolism, 2010
- Beta-catenin Nuclear Labeling is a Common Feature of Sessile Serrated Adenomas and Correlates With Early Neoplastic Progression After BRAF ActivationThe American Journal of Surgical Pathology, 2009
- Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addictionProceedings of the National Academy of Sciences of the United States of America, 2008
- Myc’s broad reachGenes & Development, 2008
- HIF and c-Myc: Sibling Rivals for Control of Cancer Cell Metabolism and ProliferationCancer Cell, 2007
- The great MYC escape in tumorigenesisCancer Cell, 2005